Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical: Archive
Medtronic's (MDT) MiniMed 780G AID System Wins New Accolade
by Zacks Equity Research
Medtronic's (MDT) MiniMed 780G system gets recognized among Fast Company's 2024 World Changing Ideas.
MDTNegative Net Change RMDNegative Net Change MEDPPositive Net Change HIMSPositive Net Change
medical medical-devices
5 Relative Price Strength Stocks With Strong Return Potential
by Nilanjan Choudhury
VITL, SFM, RCL, AEM and OGN are five stocks with explosive relative price strength.
RCLPositive Net Change AEMPositive Net Change SFMNegative Net Change VITLNegative Net Change OGNNegative Net Change
basic-materials consumer-discretionary consumer-staples medical retail
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
by Zacks Equity Research
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change ALGNNegative Net Change
medical medical-devices
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
by Zacks Equity Research
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change INSPNegative Net Change
medical medical-devices
Elevance (ELV) Rises 14.9% YTD: What Lies Ahead for Investors?
by Zacks Equity Research
Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.
BKDNegative Net Change EHCNegative Net Change SERANegative Net Change ELVNegative Net Change
medical
Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
by Zacks Equity Research
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
DYNNegative Net Change LGNDNegative Net Change SRPTNegative Net Change ANIPPositive Net Change
biotechnology biotechs medical pharmaceuticals
PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
by Zacks Equity Research
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.
LGNDNegative Net Change PTCTNegative Net Change ANIPPositive Net Change ANVSNegative Net Change
biotechnology biotechs medical pharmaceuticals
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
by Zacks Equity Research
Roche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
NVSNegative Net Change RHHBYNegative Net Change LGNDNegative Net Change ANIPPositive Net Change
medical pharmaceuticals
Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla
by Zacks Equity Research
Exelixis (EXEL) resolves two patent litigations and grants Cipla a license to market generic versions of Cabometyx in the United States beginning January 2031.
TEVAPositive Net Change EXELNegative Net Change LGNDNegative Net Change ANIPPositive Net Change
biotechnology biotechs medical pharmaceuticals
Evolus (EOLS) Releases Favorable Dermal Fillers Study Data
by Zacks Equity Research
The addition of Evolysse fillers to the company's portfolio complements Evolus' (EOLS) flagship neurotoxin Jeuveau.
MEDPPositive Net Change EOLSPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
DVAPositive Net Change ALGNNegative Net Change MCKNegative Net Change MEDPPositive Net Change
medical medical-devices
Veracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?
by Zacks Equity Research
Investors are optimistic about Veracyte (VCYT) led by strength in the testing business and upbeat guidance.
RMDNegative Net Change VCYTPositive Net Change MEDPPositive Net Change EHCNegative Net Change
medical medical-devices
Here's Why You Should Hold on to Abbott (ABT) Stock for Now
by Zacks Equity Research
Abbott's (ABT) share recovery in the Nutrition business buoys optimism.
ABTNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to About Alkermes (ALKS) stock based on the movements in the options market lately.
ALKSNegative Net Change
medical
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: UnitedHealth, Danaher, Abbott and Ark Restaurants
by Zacks Equity Research
UnitedHealth, Danaher, Abbott and Ark Restaurants are included in this Analyst Blog.
ABTNegative Net Change UNHNegative Net Change DHRNegative Net Change ARKRNegative Net Change
medical
Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data
by Zacks Equity Research
Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.
BSXNegative Net Change ECLNegative Net Change PHGPositive Net Change ALGNNegative Net Change
medical medical-devices
Masimo's (MASI) New Offering to Serve Personalized Audio Market
by Zacks Equity Research
Masimo's (MASI) new product offering is expected to enable it to expand its footprint in the personalized hearables market by offering personalized listening experiences.
ECLNegative Net Change DVAPositive Net Change MASIPositive Net Change VEEVNegative Net Change
medical medical-devices
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
by Zacks Equity Research
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.
BSXNegative Net Change ECLNegative Net Change DVAPositive Net Change VEEVNegative Net Change
medical medical-devices
BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
by Zacks Equity Research
Beigene's (BGNE) shares surge 32% in a month due to the label expansion of one of its key oncology drugs, Tevimbra, to treat three NSCLC indications, including first- and second-line use, in the EU.
LGNDNegative Net Change ANIPPositive Net Change BGNEPositive Net Change ANVSNegative Net Change
biotechnology biotechs medical oncology-screening precious-metals
Top Stock Reports for UnitedHealth, Danaher & Abbott
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and Abbott Laboratories (ABT), as well as a micro-cap stock Ark Restaurants Corp. (ARKR).
ABTNegative Net Change CMENegative Net Change UNHNegative Net Change DHRNegative Net Change INTUNegative Net Change ARKRNegative Net Change MPCPositive Net Change
medical multi-sector-conglomerates
Here's Why You Should Retain UnitedHealth Group (UNH) Stock
by Zacks Equity Research
UnitedHealth Group (UNH) remains well-poised for growth on the back of a sound customer base, acquisitions and partnerships, the telehealth services suite, and growing cash reserves.
UNHNegative Net Change THCNegative Net Change ENSGNegative Net Change PNTGPositive Net Change
medical
IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues
by Zacks Equity Research
IDEXX (IDXX) is being hurt by geopolitical instability, including the current war in Ukraine, which has affected supply chain operations globally.
IDXXNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical
Here's Why You Should Hold Surmodics (SRDX) Stock for Now
by Zacks Equity Research
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
DVAPositive Net Change ALGNNegative Net Change SRDXPositive Net Change MEDPPositive Net Change
medical medical-devices
Here's Why Investors Should Buy ResMed (RMD) Stock Now
by Zacks Equity Research
Investors are optimistic about ResMed's (RMD) potential in digital health and expansion in the international market.
RMDNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITIPositive Net Change
medical medical-devices
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
by Zacks Equity Research
This new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
AZNNegative Net Change PFENegative Net Change MRKNegative Net Change
biotechs medical pharmaceuticals